Headache, depression and anxiety: associations in the Eurolight project

The Journal of Headache and Pain

Research Article

Elena Ruiz de la Torre¹  Michel Lantéri-Minet²  Jose Miguel Laínez³  Zaza Katsarava⁴  Hallie Thomas⁵  Timothy J. Steiner⁶  Lars Jacob Stovner⁷  Colette Andrée⁸  Christian Lampl⁹  Cristina Tassorelli^1,10  Daiva Rastenyte^1,11 

[1] Asociacion Española de Pacientes con Cefalea (AEPAC), Valencia, Spain;Departement d’Evaluation et Traitement de la Douleur, Centre Hospitalo-Universitaire de Nice, Nice, France;INSERM/UdA, U1107, Neuro-Dol, Clermont-Ferrand, France;Department of Neurology, Hospital Clinico Universitario, University of Valencia, Valencia, Spain;Department of Neurology, University of Duisberg-Essen, Essen, Germany;Department of Neurology, Evangelical Hospital Unna, Unna, Germany;Department of Neuroscience, Norwegian University of Science and Technology, Edvard Griegs Gate, Trondheim, Norway;Department of Neuroscience, Norwegian University of Science and Technology, Edvard Griegs Gate, Trondheim, Norway;Division of Brain Sciences, Imperial College London, London, UK;Department of Neuroscience, Norwegian University of Science and Technology, Edvard Griegs Gate, Trondheim, Norway;Norwegian Advisory Unit on Headache, St Olavs University Hospital, Trondheim, Norway;Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland;Department of Population Health, Luxembourg Institute of Health, Strassen, Luxembourg;Headache Medical Center, Linz, Austria;Department of Neurogeriatric Medicine and Remobilisation, Hospital of the Sisters of Charity, Linz, Austria;Headache Science Centre, C Mondino National Neurological Institute, Pavia, Italy;Department of Brain and Behavioural Sciences, University of Pavia, Pavia, Italy;Lithuanian University of Health Sciences, Kaunas, Lithuania;

关键词: Headache;    Migraine;    Tension-type headache;    Medication-overuse headache;    Depression;    Anxiety;    Comorbidity;    Associations;    Public health;    Europe;    Eurolight project;    Global Campaign against Headache;   

DOI  :  10.1186/s10194-016-0649-2

 received in 2016-03-10, accepted in 2016-05-25,  发布年份 2016

来源: Springer

【 摘 要 】

BackgroundHeadache disorders and psychiatric disorders are both common, while evidence, mostly pertaining to migraine, suggests they are comorbid more often than might be expected by chance. There are good reasons for establishing whether they are: symptoms of comorbid illnesses may summate synergistically; comorbidities hinder management, negatively influencing outcomes; high-level comorbidity indicates that, where one disease occurs, the other should be looked for. The Eurolight project gathered population-based data on these disorders from 6624 participants.MethodsEurolight was a cross-sectional survey sampling from the adult populations (18–65 years) of 10 EU countries. We used data from six. The questionnaire included headache-diagnostic questions based on ICHD-II, the Headache-Attributed Lost Time (HALT) questionnaire, and HADS for depression and anxiety. We estimated odds ratios (ORs) to show associations between migraine, tension-type headache (TTH) or probable medication-overuse headache (pMOH) and depression or anxiety.ResultspMOH was most strongly associated with both psychiatric disorders: for depression, ORs (vs no headache) were 5.5 [2.2–13.5] (p < 0.0001) in males, 5.5 [2.9–10.5] (p < 0.0001) in females; for anxiety, ORs were 10.4 [4.9–21.8] (p < 0.0001) and 7.1 [4.5–11.2] (p < 0.0001). Migraine was also associated with both: for depression, ORs were 2.1 [1.3–3.4] (p = 0.002) and 1.8 [1.1–3.1] (p = 0.030); for anxiety 4.2 [2.8–6.3] (p < 0.0001) and 2.4 [1.7–3.4] (p < 0.0001). TTH showed associations only with anxiety: ORs 2.5 [1.7–3.7] (p < 0.0001) for males, 1.5 [1.1–2.1] (p = 0.021) for females. Participants with migraine carried 19.1 % probability of comorbid anxiety, 6.9 % of depression and 5.1 % of both, higher than the representative general-population sample (14.3, 5.6 and 3.8 %). Probabilities in those with MOH were 38.8, 16.9 and 14.4 %; in TTH, they did not exceed those of the whole sample. Comorbid psychiatric disorder did not add to headache-attributed productive time losses, but weak associations existed (R2 = 0.020–0.082) for all headache types between lost productive time and probabilities of depression and, less so, anxiety.ConclusionIn this large study we confirmed that depression and especially anxiety are comorbid more than by chance with migraine, and showed the same is true, but more strongly, with MOH. Arguably, migraine patients and, more certainly, MOH patients should be screened with HADS in pursuit of best outcomes.

【 授权许可】

CC BY   
© The Author(s). 2016